FLUOROCHEMNSEGujarat Fluorochemicals Limited· Chemicals & PetrochemicalsHighNeutral
Announced Tue, 11 Nov, 2025 · 16:22 IST

Q2 FY26 results approved; PAT up 35% standalone, 48% consolidated

Pat Growth 25pctEbitda Margin ExpansionRevenue DeclineResults View source PDFExplain this filing

FLUOROCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+6.0%Reaction day
₹3479.60
prior close
₹3555.00
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.8%+5.3% vs market
Specialty Chemicals peers, median of 85sector+0.7%+5.4% vs sector

On the reaction day the stock moved 5.3 pts more than Nifty Midcap 150 and 5.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
+0.5
15m
+0.1
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+6.0+0.8+5.3+0.7+5.4
Next day
+3.5+0.4+3.0+0.4+3.1
2d
+1.8+0.5+1.4+0.4+1.4
3d
+2.9+1.2+1.8-0.2+3.1
4d
+2.9+0.5+2.4-1.2+4.1
5d
+1.0+0.9+0.1-2.2+3.1
1w
+0.2-0.3+0.5-2.3+2.5
15d
-3.3-0.4-2.9-4.2+0.9
1m
-0.7-0.3-0.4-5.2+4.5
2m
-0.6-1.2+0.6-9.3+8.7
3m
-3.4+0.1-3.6-9.0+5.5
UpDownMarket · Nifty Midcap 150Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY26 unaudited results (ended Sept 30, 2025). Standalone Q2: revenue Rs 1,131 cr, PAT Rs 195 cr versus Rs 144 cr prior year, EBITDA Rs 360 cr. Consolidated Q2: revenue Rs 1,210 cr, PAT Rs 179 cr versus Rs 121 cr. Standalone operating margin expanded to 25.98 percent from 19.08 percent. Two new whole-time directors appointed, one resigned citing personal reasons. Auditors issued unmodified review report.

Likely market impact

Profit and EBITDA margins improved sharply year on year. Leadership transition with three director changes.